Dog Health Research

Canine Parvovirus & Distemper: Research Library

The full DOI-linked reference base behind these pages, grouped by topic, with every open-access paper hosted here for direct download.

A note on how to use this. I'm a medical technologist who assembled this library while researching how the worst dog diseases are being treated, not a veterinarian, and nothing here is medical or veterinary advice. It's a reference shelf: the primary literature, linked to its source, so a clinician can read the evidence directly and decide. Any treatment decision belongs with a qualified veterinarian who knows the individual patient.

This is the reference library that sits underneath the canine parvovirus and canine distemper research on this site. Every entry links straight to its DOI or publisher. Where a paper is open access and freely re-distributable, its PDF is hosted here so you can download it in one click, no paywall, no login. Where a paper is paywalled, the link takes you to the publisher's landing page. A handful of newer findings are still being indexed and are marked accordingly rather than given an invented link.

For the narrative syntheses that draw on these sources, see the distemper treatment synthesis and the CPV research pages.

70References
31Hosted PDFs
4Topic groups

The reference library


Grouped by topic. Download PDF means the open-access file is hosted here. A plain DOI link goes to the publisher (open or paywalled). Items marked citation pending are recent findings not yet publicly indexed, shown without a fabricated link.

CPV: treatment, prevention & diagnostics
  • Tarpey et al. (2023). Nobivac DP PLUS recombinant CPV-2c challenge study. Vaccines 11(9):1499 (PMC10534519) https://doi.org/10.3390/vaccines11091499. Download PDF
  • Ulas et al. (2023). Four-arm antiviral trial in CPV (IFN-omega best, 85.7%). J Vet Sci (PMC10839179) https://doi.org/10.4142/jvs.23139. Download PDF
  • NTZ mechanism transcriptomic study (G2/M arrest, JAK-STAT). Viruses 16(2):282, 2024 (PMC10892128) https://doi.org/10.3390/v16020282. Download PDF
  • CPV advances review (CPV-2c, vaccine gaps, treatment landscape). Microorganisms 13(1):47, 2025 (PMC11767475) https://doi.org/10.3390/microorganisms13010047. Download PDF
  • Pereira et al. (2018). Fecal microbiota transplantation in CPV enteritis RCT. J Vet Intern Med (PMC5867004) https://doi.org/10.1111/jvim.15072. Download PDF
  • NTZ drug screen of 1,430 FDA-approved drugs against CPV. Viruses 11(8):742, 2019 (PMC6724046) https://doi.org/10.3390/v11080742. Download PDF
  • CPV-circovirus co-infection (Kazakhstan). Front Cell Infect Microbiol 2025 https://doi.org/10.3389/fcimb.2025.1645697. Download PDF
  • Martin et al. (2002). Treatment of canine parvoviral enteritis with interferon-omega, placebo-controlled challenge trial. Vet Microbiol 89(2-3):115-27 (PMID 12243889) https://doi.org/10.1016/s0378-1135(02)00173-6.
  • de Mari et al. (2003). IFN-omega placebo-controlled field trial. Vet Rec 152(4):105-8 (PMID 12572939) https://doi.org/10.1136/vr.152.4.105.
  • Pedroza-Roldán et al. (2014/2015). Genotyping of canine parvovirus in western Mexico. J Vet Diagn Invest 27(1):107-11 (PMID 25525144) https://doi.org/10.1177/1040638714559969.
  • Venn et al. (POPS Trial) (2017). Evaluation of an outpatient protocol in canine parvoviral enteritis. J Vet Emerg Crit Care 27(1):52-65 (PMID 27918639) https://doi.org/10.1111/vec.12561.
  • Lim et al. (2024). CPMA monoclonal challenge study (0% vs 57% mortality); basis for Trutect approval. JAVMA 262(4) Read at source.
  • (Jalisco field PDF) Parvovirus CPV-2c en Jalisco. Local NotebookLM/AI-generated briefing PDF. citation pending / not yet indexed
  • Pedroza-Roldán et al. (2024). First complete CPV-2c genomes from Mexico (T226S, F267Y, A440T). citation pending / not yet indexed
  • Pedroza-Roldán et al. (2026). CPV-2c cytokine panel (low IFN-gamma = survival; high IL-6/IL-8/MCP-1/IL-10 = poor outcome). citation pending / not yet indexed
  • Cornell tocilizumab / canine IL-6 receptor study. Front Vet Sci Sept 2025 citation pending / not yet indexed
  • Winston et al. (2025). FMT for CPV, 18-institution consortium (ongoing). JAVMA 2025 citation pending / not yet indexed
  • Guallasamín-Quisilema et al. (2023). Ecuador outpatient CPV (85.3% survival; CRP/lactate biomarkers). citation pending / not yet indexed
CDV: antivirals & acute-phase treatment
CDV: neurological sequelae, myoclonus & demyelination
Human-neurology background (myoclonus & botulinum toxin)

Individual paper pages


Each of the 31 hosted open-access papers also has its own indexable page: full citation, a factual one-line note on why it matters, the DOI, and a direct PDF download.

Reference set compiled from the DogHealth PDF library manifest (60 unique works, 70 catalogued entries), deduplicated across the CPV and distemper research. Open-access status was classified by publisher license; MDPI, Frontiers, PLOS, BMC, Heliyon, Scientific Reports, PMC-OA, and freely distributable government and society PDFs are hosted here under their open licenses. Paywalled works link to the publisher only.

This library is provided for clinical information and is not a substitute for hands-on veterinary care. Treatments described in the underlying literature as experimental or off-label are exactly that, and should be considered only in consultation with a qualified veterinarian and with informed owner consent.